INVESCO QQQ TR's ticker is QQQ and the CUSIP is 46090E103. A total of 1,184 filers reported holding INVESCO QQQ TR in Q4 2018. The put-call ratio across all filers is 1.70 and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,761,000 | -39.6% | 6,282 | -21.9% | 0.21% | -28.4% |
| Q1 2022 | $2,915,000 | -1.5% | 8,040 | +8.1% | 0.29% | +2.5% |
| Q4 2021 | $2,958,000 | +336.3% | 7,435 | +292.3% | 0.28% | +97.9% |
| Q3 2021 | $678,000 | +0.9% | 1,895 | 0.0% | 0.14% | +2.9% |
| Q2 2021 | $672,000 | -46.4% | 1,895 | -54.9% | 0.14% | -9.7% |
| Q1 2021 | $1,254,000 | +118.1% | 4,199 | +102.9% | 0.16% | +5.4% |
| Q4 2020 | $575,000 | 0.0% | 2,070 | 0.0% | 0.15% | 0.0% |
| Q3 2020 | $575,000 | +9.9% | 2,070 | +1.7% | 0.15% | +8.1% |
| Q2 2020 | $523,000 | +28.8% | 2,035 | -4.5% | 0.14% | -0.7% |
| Q1 2020 | $406,000 | +75.8% | 2,131 | +96.2% | 0.14% | +128.3% |
| Q4 2019 | $231,000 | +12.7% | 1,086 | 0.0% | 0.06% | +5.3% |
| Q3 2019 | $205,000 | +1.0% | 1,086 | 0.0% | 0.06% | -1.7% |
| Q2 2019 | $203,000 | -53.8% | 1,086 | -61.8% | 0.06% | -64.4% |
| Q4 2018 | $439,000 | -17.0% | 2,846 | 0.0% | 0.16% | +11.6% |
| Q3 2018 | $529,000 | +8.2% | 2,846 | 0.0% | 0.15% | +2.8% |
| Q2 2018 | $489,000 | – | 2,846 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Davide Leone & Partners Investment Co Ltd. | 2,584,300 | $925,076,000 | 70.85% |
| Susquehanna Foundation | 673,923 | $241,237,000 | 58.96% |
| Artemis Wealth Advisors, LLC | 1,914,580 | $343,014,285 | 47.70% |
| Sante Capital Fund, LP | 137,500 | $49,220,000 | 45.45% |
| 36 SOUTH CAPITAL ADVISORS LLP | 4,161,100 | $1,489,507,000 | 39.65% |
| Thinkbetter Group LLC | 105,099 | $38,841,000 | 39.57% |
| Coltrane Asset Management L.P. | 429,500 | $153,744,000 | 39.31% |
| Hidden Lake Asset Management LP | 300,000 | $107,388,000 | 28.36% |
| Frank, Rimerman Advisors LLC | 191,000 | $68,370,425 | 26.41% |
| Alkeon Capital Management | 42,750,000 | $15,302,789,000 | 25.83% |